In rodent models of ischemic stroke, albumin therapy has been shown to exhibit significant neuroprotective effects, including reduced brain infarct volume, improved neurological scores, and normalization of diffusion-weighted imaging changes (Belayev et al., 1997; Tang et al., 2009). The gene discussed is ALB; the disease is ischemic stroke.